Mackenzie Financial
DXCM icon

Mackenzie Financial’s DexCom DXCM Stock Holding History

Mackenzie Financial’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.9K Buy
+14,800
New +$986K ﹤0.01% 1537

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Mackenzie Financial's DXCM Position: Q2 2026 in Review

Mackenzie Financial reduced its DexCom (DXCM) stake by 84% in Q2 2026, selling an estimated $67.1M and leaving 197,082 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #546.

Mackenzie Financial first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $129M in Q1 2019. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Mackenzie Financial held 197,082 shares of DexCom worth $13.3M as of Q2 2026.
  • Mackenzie Financial sold 1,006,863 DexCom shares in Q2 2026, an estimated $67.1M.
  • DexCom made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #546 holding.
  • Mackenzie Financial first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
  • Mackenzie Financial's DexCom position peaked at $129M in Q1 2019.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.